Mercy Iowa terminated its agreement with EMR software company Altera Digital Health, opting to transfer over to University of Iowa Health Care, with Altera expected to continue operations during the transition. The move happens as University of Iowa continues its acquisition of Mercy Iowa. The contentious exit strategy had previously led Altera to seek judicial intervention.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
